AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it will present a preclinical ...

Unsupervised use of psilocybin has risen dramatically among youth and adults 30 and older, along with a corresponding rise in ...

One year of Tysabri infusion improved working ability for relapsing-remitting multiple sclerosis (RRMS) patients in France, ...

According to a nurse practitioner who works in myeloma research, nurses and APPs are responsible for much of the clinical work with patients involved in trials.

AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...

MONDAY, April 21, 2025 (HealthDay News) -- There’s a biological reason why heavy weed users are at increased risk of psychosis, a new study says. People with cannabis use disorder have higher levels ...

Research from Harvard Kennedy School’s Marcella Alsan shows Black survey respondents’ interest in clinical trials increased ...

The CT Clinical Innovation Center at Mayo Clinic has a robust roster of faculty, staff and alumni committed to advancing CT imaging technology and methods to reduce radiation doses.

A laureate professor working on early diagnosis of ALS, or Amyotrophic Lateral Sclerosis, is one of several Harvard University researchers who have received stop-work orders after the Trump ...

When President Donald Trump named Robert F. Kennedy Jr. as his choice to lead the US Department of Health and Human Services, ...

A mid-afternoon puff of a preventer inhaler could be the best way for a person with asthma to keep their symptoms under ...